SPARC Partnership Opportunity: Custom Arrangements for Device-Based Clinical Studies with Flexible Data and Intellectual Property Rights

The purpose of this Partnership Opportunity (PO) is to create customized partnerships between NIH and successful applicants to maximize the scientific impact of human device studies through the collection of research data beyond those addressing clinical health end-points. Proposals must involve device-based clinical studies of neuromodulation, targeting the peripheral nervous system or the spinal cord. Such data, which might be obtained as part of ongoing, planned or new studies, would serve to enhance mechanistic knowledge about a neuromodulatory intervention and/or provide other physiological or anatomical insights in support of SPARC’s mission to create anatomical and functional peripheral neural circuit maps.

Beginning in 2019, NIH plans to fund approximately $23M in total costs over a 3-year period through this PO. Proposal budgets are not limited but need to reflect the actual needs of the proposed project.

The program will custom-design arrangements in which budget segments may depend on prepublication sharing of specified data. Award levels and total budget may increase or decrease over time based on programmatic needs, funding availability and awardee performance.

This funding opportunity is part of a Common Fund Initiative directed from the NIH Office of the NIH Director, Office of Strategic Coordination. The PO will be administered by the National Center for Advancing Translational Sciences (NCATS) on behalf of the NIH.

Key Dates:

  • Mandatory Letter of Intent – due September 7, 2018 by 11:59pm ET
  • Proposal – due October 15, 2018 by 11:59pm ET
  • Earliest award start date – February 4, 2019

Learn more.

Posted: July 20, 2018